Skip to main content
Log in

Immunohistochemical expression of E-cadherin in metastatic brain tumors

  • Original Article
  • Published:
Brain Tumor Pathology Aims and scope Submit manuscript

Abstract

The adhesion molecule E-cadherin has been shown to influence malignant transformation of tumors, including local and distant metastases. We examined the expression of E-cadherin to determine its relationship to the development of metastasis in metastatic brain tumors. Immunohistochemistry for E-cadherin and Ki-67 was carried out in 76 formalin-fixed, paraffin-embedded archival specimens of metastatic brain tumors and in 14 corresponding available primary tumors from patients who received treatment for metastatic brain tumors. The primary tumors were mainly lung cancers (51.3%), followed by gastrointestinal tumors (28.9%). E-cadherin was expressed in 62 (81.5%) of 76 cases examined. In metastatic adenocarcinomas, a consistent tendency for E-cadherin expression was noted, regardless of the degree of differentiation or the extent of spread of the disease (P=0.4). There was a direct correlation between E-cadherin expression and high MIB-1 index in all metastatic brain tumors (P=0.0007). Pairwise analysis in 14 primary tumors and the corresponding metastatic specimens revealed high E-cadherin and MIB-1 staining in metastatic brain tumors. These results provide a unique association between E-cadherin, systemic metastasis, and proliferation potential in metastatic brain tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Patchel RA, Tibbs PA, Walsh TW, et al (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494–500

    Article  Google Scholar 

  2. D’Amico T, Thomas AA, Mary-Berth HM, et al. (2001) Predicting the site of metastasis from lung cancer using molecular biological markers. Ann Thorac Surg 72:1144–1148

    Article  PubMed  CAS  Google Scholar 

  3. Tanaka M, Kitajima Y, Edakuni G, et al (2002) Abnormal expression of E cadherin and beta catenin may be a molecular marker of submucosal invasion and lymph node metastasis in early gastrointestinal cancers. Br J Surg 89:236–244

    PubMed  CAS  Google Scholar 

  4. Karatzas G, Karayiannakis AJ, Syrigos KN, et al (2000) Expression patterns of the E cadherin-catenin cell-cell adhesion complex in gastric cancers. Hepatogastoenterology 47:1465–1469

    CAS  Google Scholar 

  5. Berx G, Van Roy F (2001) The E cadherin/catenin complex: an important gate keeper in breast cancer tumorigenesis and malignant progression. Breast Cancer Res 3:289–293

    Article  PubMed  CAS  Google Scholar 

  6. Shibanuma H, Hirano T, Tsuji K, et al (1998) Influence of E cadherin dysfunction upon local invasion and metastasis in non small cell lung carcinoma. Lung Cancer 22:85–95

    Article  PubMed  CAS  Google Scholar 

  7. Hunt NC, Douglas-Jones AG, Jasani B, et al (1997) Reduced E cadherin and node metastasis in breast cancer. Virchows Arch 430:285–289

    Article  PubMed  CAS  Google Scholar 

  8. Cai J, Ikeguchi M, Tsujitani S, et al. (2001) Significant correlation between micrometastases in the lymph nodes and reduced expression of E cadherin in early gastric cancer. Gastric Cancer 4:66–74

    Article  PubMed  CAS  Google Scholar 

  9. Akimoto T, Kawabe S, Grothey A, et al (1999) Low E cadherin and beta catenin expression correlates with increased spontaneous and artificial lung metastasis of murine carcinoma. Clin Exp Metastasis 17:171–176

    Article  PubMed  CAS  Google Scholar 

  10. Lim SC, Jang IG, Kim YC, et al (2000) The role of E cadherin expression in non small cell lung carcinoma. J Korean Med Sci 15:501–506

    PubMed  CAS  Google Scholar 

  11. Yoshida R, Kimura N, Harada Y, et al (2001) Loss of E cadherin, alpha, beta catenin expression is associated with metastasis and poor prognosis in invasive carcinoma of breast. Int J Oncol 18:513–520

    PubMed  CAS  Google Scholar 

  12. Sulzer MA, Leers MP, Van Noord JA, et al (1998) Reduced E cadherin expression is associated with increased lymph node metastasis and unfavourable prognosis in non small cell lung cancer. Am J Respir Crit Care Med 157:1319–1323

    PubMed  CAS  Google Scholar 

  13. Kase S, Sugio K, Yamazaki K, et al (2000) Expression of E cadherin and beta catenin in human non small cell carcinoma and the clinical significance. Clin Cancer Res 6:4789–4796

    PubMed  CAS  Google Scholar 

  14. Herbst RS, Yano S, Kuniyasu H, et al (2000) Differential expression of E cadherin and type IV collagenase genes predict outcome in patients with non small cell lung carcinoma. Clin Cancer Res 6:790–797

    PubMed  CAS  Google Scholar 

  15. Liu D, Huang C, Kameyama K et al (2001) E cadherin expression associated with differentiation and prognosis in patients with non small cell lung cancer. Ann Thorac Surg 71:949–954

    Article  PubMed  CAS  Google Scholar 

  16. Lee YC, Wu CT, Chen CS, et al (2000) E cadherin expression in surgically resected non small cell lung cancers—a clinicopathological study. Thorac Cardiovasc Surg 48:294–299

    Article  PubMed  CAS  Google Scholar 

  17. Nakajo A, Natsugoe S, Ishigami S, et al (2001) Detection and prediction of micrometastasis in the lymph nodes of patients with pN0 gastric cancer. Ann Surg Oncol 8:158–162

    PubMed  CAS  Google Scholar 

  18. Arnold SM, Young AB, Munn RK, et al (1999) Expression of p53, bcl-2, E cadherin, MMP-9 and TIMP-1 in paired primary tumors and brain metastasis. Clin Cancer Res 5:4028–4033

    PubMed  CAS  Google Scholar 

  19. Bukholm IK, Nesland JM, Borresen-Dale AL, et al (2000) Reexpression of E cadherin, alpha catenin and beta catenin, but not gamma catenin in metastatic tissue from breast cancer patients. J Pathol 190:15–19

    Article  PubMed  CAS  Google Scholar 

  20. Kitange G, Kishikawa M, Nakayama T, et al (1999) Expression of Ets 1 proto oncogene correlates with malignant potential in human astrocytic tumors. Mod Pathol 12:618–626

    PubMed  CAS  Google Scholar 

  21. Walker AE, Robins M, Weinfeld FD (1985) Epidemiology of brain tumors: the national survey of intracranial neoplasms. Neurology 35:219–226

    PubMed  CAS  Google Scholar 

  22. Ikeguchi M, Taniguchi T, Makino M, et al (2000) Reduced E cadherin expression and enlargement of cancer nuclei strongly correlates with hematogenic metastasis in colorectal adenocarcinoma. Scand J Gastoenterol 35:839–846

    Article  CAS  Google Scholar 

  23. Karube H, Masuda H, Ishii Y, et al (2002) E-cadherin expression is inversely proportional to tumor size in experimental liver metastases. J Surg Res 106:173–178

    Article  PubMed  CAS  Google Scholar 

  24. Ikeguchi M, Makino M, Kaibara N (2001) Clinical significance of E-cadherin/catenin complex expression in metastatic foci of colorectal carcinoma. J Surg Oncol 77:201–207

    Article  PubMed  CAS  Google Scholar 

  25. Liu J, Ikeguchi M, Nakamura S, et al (2002) Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival. J Exp Clin Cancer Res 21:65–71

    PubMed  Google Scholar 

  26. Byers SW, Sommers CL, Hoxter B, et al (1995) Role of E cadherin in response of tumor cell aggregates to lymphatic, venous and arterial flow; measurement of cell-cell adhesion strength. J Cell Sci 108:2053–2064

    PubMed  CAS  Google Scholar 

  27. Graff JR, Gabrielson E, Fujii H, et al (2000) Methylation patterns of the 5′CpG islands are unstable and reflect the dynamic, heterogeneous loss of E cadherin during metastasis progression. J Biol Chem 275:2727–2732

    Article  PubMed  CAS  Google Scholar 

  28. Cowley GP, Smith ME (1995) Modulation of E cadherin expression and morphological phenotype in the intravascular component of adenocarcinomas. Int J Cancer 60:325–329

    Article  PubMed  CAS  Google Scholar 

  29. Al Mehdi AB, Tozawa K, Fisher AB, et al (2000) Intravascular origin of metastasis from the proliferation of endothelium attached tumor cells: a new model for metastasis. Nature Med 6:100–102

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hamisi Kimaro Shabani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Shabani, H.K., Kitange, G., Tsunoda, K. et al. Immunohistochemical expression of E-cadherin in metastatic brain tumors. Brain Tumor Pathol 20, 7–12 (2003). https://doi.org/10.1007/BF02478941

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02478941

Key words

Navigation